We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





Hyperfine Demonstrates World’s First FDA-Cleared, Portable, Ultra-Low-Field, MR Brain Imaging System

By MedImaging International staff writers
Posted on 27 Nov 2023
Print article
Image: Swoop, the world’s first FDA-cleared, portable, ultra-low-field, MR brain imaging system is showcased at RSNA 2023 (Photo courtesy of Hyperfine)
Image: Swoop, the world’s first FDA-cleared, portable, ultra-low-field, MR brain imaging system is showcased at RSNA 2023 (Photo courtesy of Hyperfine)

Hyperfine (Guilford, CT, USA) is showcasing the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop system—at RSNA 2023. The Swoop system which is capable of providing imaging at multiple points of care received initial U.S. Food and Drug Administration (FDA) clearance in 2020. It is a portable ultra-low-field MRI device for producing images that display the internal structure of the head where a full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. Traditionally, access to costly, stationary, conventional MRI technology can be inconvenient or not available when needed most. With the portable, ultra-low-field Swoop system, Hyperfine, Inc. is redefining the neuroimaging workflow by bringing brain imaging to the patient’s bedside.

In addition, Hyperfine is presenting three scientific sessions highlighting ultra-low-field imaging data at RSNA 2023. These studies analyzed how portable MR brain imaging may assist physicians in the diagnosis and management of neurological conditions in critical care settings. The first session titled ‘Longitudinal Relaxivity Estimation of Gadolinium-based Contrast Agents’ is being presented by Sudarshan Ragunathan, Ph.D., and the second session titled ‘A Generative Adversarial Network Approach for Low-field to High-field Image Translation’ is being presented by Alfredo Lucas. The third session titled ‘Point-of-care Brain MRI: Update on Preliminary Results from a Single-center Retrospective Study in the Neurocritical Care Setting’ is being presented by Brian Gerard Yep, MD.

“At Hyperfine, Inc., we strive to push the boundaries of medical technology to make MR brain imaging more accessible, and our presence at RSNA 2023 underscores the promise of expanded use cases for portable MR brain imaging technology,” said Chip Truwit, MD, Hyperfine, Inc. vice president of scientific affairs. “We’ll continue to prioritize clinical application research for the Swoop system because expanding access to portable MR brain imaging is critical in improving how patient care is delivered.”

Related Links:
Hyperfine 

3T MRI Scanner
MAGNETOM Cima.X
New
Post-Processing Imaging System
DynaCAD Prostate
X-ray Diagnostic System
FDX Visionary-A
Portable Color Doppler Ultrasound Scanner
DCU10

Print article

Channels

Radiography

view channel
Image: The new machine algorithm can identify cardiovascular risk at the click of a button (Photo courtesy of Adobe Stock)

Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans

A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more

MRI

view channel
Image: In brains of control mice (left) and PD mice (right), from bottom to top: neuronal activity in a representative animal (Photo courtesy of Ruxanda Lungu/FC)

Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable

Parkinson's disease (PD) remains a challenging condition to treat, with no known cure. Though therapies have improved over time, and ongoing research focuses on methods to slow or alter the disease’s progression,... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.